Sunrise-related headache: Case report

Cephalalgia

Volumn 30, Issue 1, 2010, Pages 118-122

  Ulas, U H ^a   Korkmaz, A ^b   Karadas, O ^a   Odabasi, Z ^a   Reiter, R J ^b  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Headache; Hypothalamic lesion; Melatonine

Indexed keywords

CORTICOTROPIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MELATONIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BLOOD EXAMINATION; BRAIN INFARCTION; CASE REPORT; CLINICAL FEATURE; FOLLOW UP; HEADACHE; HUMAN; HYPOTHALAMUS; MALE; MEDICAL DECISION MAKING; MORBIDITY; NEUROEPITHELIAL BODY; NUCLEAR MAGNETIC RESONANCE IMAGING; PINEAL BODY;

ADULT; CEREBRAL INFARCTION; CIRCADIAN RHYTHM; CYSTS; HEADACHE DISORDERS; HUMANS; HYPOTHALAMUS; MAGNETIC RESONANCE IMAGING; MALE; MELATONIN;

EID: 77956233927     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2009.01876.x     Document Type: Article

References (37)

1. Hastings MH, Reddy AB, Maywood ES. A clockwork web: circadian timing in brain and periphery, in health and disease. Nat Rev Neurosci 2003;4:649-61.
2. Reppert SM, Weaver DR. Coordination of circadian timing in mammals. Nature 2002;418:935-41.
3. Claustrat B, Loisy C, Brun J, Beorchia S, Arnaud JL, Chazot G. Nocturnal plasma melatonin levels in migraine: a preliminary report. Headache 1989;29:242-5.
4. Murialdo G, Fonzi S, Costelli P, Solinas GP, Parodi C, Marabini S, et al. Urinary melatonin excretion throughout the ovarian cycle in menstrually related migraine. Cephalalgia 1994;14:205-9.
5. Peres MF, Sanchez del Rio M, Seabra ML, Tufik S, Abucham J, Cipolla-Neto J, et al. Hypothalamic involvement in chronic migraine. J Neurol Neurosurg Psychiatry 2001;71:747-51.
6. Claustrat B, Brun J, Chiquet C, Chazot G, Borson-Chazot F. Melatonin secretion is supersensitive to light in migraine. Cephalalgia 2004;24:128-33.
7. Salvesen R, Bekkelund SI. Migraine, as compared to other headaches, is worse during midnight-sun summer than during polar night. A questionnaire study in an Arctic population. Headache 2000;40:824-9.
8. Chronicle EP, Mulleners WM. Visual system dysfunction in migraine: a review of clinical and psychophysical findings. Cephalalgia 1996;16:525-35 (discussion 3).
9. Schoenen J. Cortical electrophysiology in migraine and possible pathogenetic implications. Clin Neurosci 1998;5:10-17.
10. Hay KM, Mortimer MJ, Barker DC, Debney LM, Good PA. 1044 women with migraine: the effect of environmental stimuli. Headache 1994;34:166-8.
11. Cutrer FM. Antiepileptic drugs: how they work in headache. Headache 2001;41(Suppl. 1):S3-10.
12. Lampl C, Buzath A, Klinger D, Neumann K. Lamotrigine in the prophylactic treatment of migraine aura-a pilot study. Cephalalgia 1999;19:58-63.
13. Provencio I, Rollag MD, Castrucci AM. Photoreceptive net in the mammalian retina. This mesh of cells may explain how some blind mice can still tell day from night. Nature 2002;415:493.
14. Peres MF. Melatonin, the pineal gland and their implications for headache disorders. Cephalalgia 2005;25:403-11.
15. Balsalobre A. Clock genes in mammalian peripheral tissues. Cell Tissue Res 2002;309:193-9.
16. Panda S, Antoch MP, Miller BH, Su AI, Schook AB, Straume M, et al. Coordinated transcription of key pathways in the mouse by the circadian clock. Cell 2002;109:307-20.
17. Bolli GB, De Feo P, De Cosmo S, Perriello G, Ventura MM, Calcinaro F, et al. Demonstration of a dawn phenomenon in normal human volunteers. Diabetes 1984;33:1150-3.
18. Bolli GB, Gerich JE. The 'dawn phenomenon'-a common occurrence in both non-insulin-dependent and insulin-dependent diabetes mellitus. N Engl J Med 1984;310:746-50.
19. La Fleur SE, Kalsbeek A, Wortel J, Buijs RM. A suprachiasmatic nucleus generated rhythm in basal glucose concentrations. J Neuroendocrinol 1999;11:643-52.
20. Kalsbeek A, La Fleur S, Van Heijningen C, Buijs RM. Suprachiasmatic GABAergic inputs to the paraventricular nucleus control plasma glucose concentrations in the rat via sympathetic innervation of the liver. J Neurosci 2004;24:7604-13.
21. Colombari E, Sato MA, Cravo SL, Bergamaschi CT, Campos RR Jr, Lopes OU. Role of the medulla oblongata in hypertension. Hypertension 2001;38:549-54.
22. Sved AF, Ito S, Sved JC. Brainstem mechanisms of hypertension: role of the rostral ventrolateral medulla. Curr Hypertens Rep 2003;5:262-8.
23. Wilson CG, Bonham AC. Area postrema excites and inhibits sympathetic-related neurons in rostral ventrolateral medulla in rabbit. Am J Physiol 1994;266: H1075-86.
24. Skinner DC, Malpaux B. High melatonin concentrations in third ventricular cerebrospinal fluid are not due to Galen vein blood recirculating through the choroid plexus. Endocrinology 1999;140:4399-405.
25. Shaw PF, Kennaway DJ, Seamark RF. Evidence of high concentrations of melatonin in lateral ventricular cerebrospinal fluid of sheep. J Pineal Res 1989;6:201-8.
26. Longatti P, Perin A, Rizzo V, Comai S, Giusti P, Costa CV. Ventricular cerebrospinal fluid melatonin concentrations investigated with an endoscopic technique. J Pineal Res 2007;42:113-18.
27. Silva SO, Ximenes VF, Livramento JA, Catalani LH, Campa A. High concentrations of the melatonin metabolite, N1-acetyl-N2-formyl-5- methoxykynuramine, in cerebrospinal fluid of patients with meningitis: a possible immunomodulatory mechanism. J Pineal Res 2005;39:302-6.
28. Reiter RJ, Tan DX, Manchester LC, Pilar Terron M, Flores LJ, Koppisepi S. Medical implications of melatonin: receptor-mediated and receptor-independent actions. Adv Med Sci 2007;52:11-28.
29. Chaturvedi N, Sjolie AK, Stephenson JM, Abrahamian H, Keipes M, Castellarin A, et al. Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus. Lancet 1998;351:28-31.
30. Dubocovich ML. Agomelatine targets a range of major depressive disorder symptoms. Curr Opin Investig Drugs 2006;7:670-80.
31. Montgomery SA, Kasper S. Severe depression and antidepressants: focus on a pooled analysis of placebocontrolled studies on agomelatine. Int Clin Psychopharmacol 2007;22:283-91.
32. Pjrek E, Winkler D, Konstantinidis A, Willeit M, Praschak-Rieder N, Kasper S. Agomelatine in the treatment of seasonal affective disorder. Psychopharmacol (Berl) 2007;190:575-9.
33. Coloma FM, Niles LP. Melatonin enhancement of [3H]-gamma-aminobutyric acid and [3H]muscimol binding in rat brain. Biochem Pharmacol 1988;37:1271-4.
34. Niles LP, Pickering DS, Arciszewski MA. Effects of chronic melatonin administration on GABA and diazepam binding in rat brain. J Neural Transm 1987;70:117-24.
35. Wang F, Li J, Wu C, Yang J, Xu F, Zhao Q. The GABA (A) receptor mediates the hypnotic activity of melatonin in rats. Pharmacol Biochem Behav 2003;74:573-8.
36. Shavali S, Ho B, Govitrapong P, Sawlom S, Ajjimaporn A, Klongpanichapak S, Ebadi M. Melatonin exerts its analgesic actions not by binding to opioid receptor subtypes but by increasing the release of beta-endorphin an endogenous opioid. Brain Res Bull 2005;64:471-9.
37. Barreca T, Siani C, Franceschini R, Francaviglia N, Messina V, Perria C, Rolandi E. Diurnal beta-endorphin changes in human cerebrospinal fluid. Life Sci 1986;38:2263-7.